MedPath

EMA Approvals

European Medicines Agency approved drug marketing authorisations and regulatory information

European Medicines Agency
European Union
1,960 Approvals
Showing 661 to 680 of 1,960 approvalsPage 34 of 98

Talzenna

Authorisation: Jun 20, 2019

Pazenir

Authorisation: May 6, 2019

Lorviqua

Authorisation: May 6, 2019

Palynziq

Authorisation: May 3, 2019

Ondexxya

Authorisation: Apr 26, 2019

Ondexxya

Authorisation: Apr 26, 2019

Skyrizi

Authorisation: Apr 26, 2019

Skyrizi

Authorisation: Apr 26, 2019

Vizimpro

Authorisation: Apr 2, 2019

Idacio

Authorisation: Apr 2, 2019

Idacio

Authorisation: Apr 2, 2019

Febuxostat Krka

Authorisation: Mar 28, 2019

Ajovy

Authorisation: Mar 28, 2019

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.